Oral wegovy, containing the active ingredient semaglutide, is a GLP-1 receptor agonist
(2024) Prescribing semaglutide for weight loss in non-diabetic, obese patients is associated with an increased risk of erectile dysfunction: a TriNetX database study Wallace, Ian R, et al (2012) Sex hormone binding globulin and insulin resistance Bhasin S, Lincoff AM, Nissen SE, et al
If found to be a candidate for Semaglutide, she explains how dosing works, how to administer the medication yourself, how to store the medication, and what you can expect during the first few weeks as your body adjusts
To minimize the possibility of aggravating nausea - a typical side effect when initiating this drug therapy, it is advisable to avoid coffee intake on an empty stomach, particularly in the morning